Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9663668 | 0.84 | P2RX7 (0.30) | P2RX7 | |
| SCHEMBL1608163 | 0.81 | ALDH1A1 (0.48) | — | |
| SCHEMBL3212184 | 0.80 | — | — | |
| SCHEMBL381885 | 0.80 | — | — | |
| SCHEMBL6243277 | 0.80 | — | — | |
| Potassium Ion SCHEMBL21373230 | 0.78 | — | — | |
| SCHEMBL7377426 | 0.78 | — | — | |
| SCHEMBL10798864 | 0.78 | LTA4H (0.47) | — | |
| SCHEMBL8692782 | 0.77 | S1PR2 (0.35) | — | |
| SCHEMBL4760562 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116396303-B | Gimalane-guaiane sesquiterpene dimer and preparation method and application thereof | 中国科学院昆明植物研究所 | 2025-02-18 | — | — | CN | claimed |
| CN-118676436-A | Electrolyte and lithium ion battery | 深圳市豪鹏科技股份有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-114727912-B | Cross-linked hyaluronic acid butyrate or butyrate-formate derivative and cross-linking method thereof | 贝曼吉制药公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117534654-A | Method for preparing dabigatran etexilate intermediate by micro-channel method | 江苏阿尔法集团盛基药业(宿迁)有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-117447448-A | Synthesis method of dabigatran etexilate intermediate | 江苏阿尔法集团盛基药业(宿迁)有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116848092-A | Process for preparing pyrimidine cyclohexyl glucocorticoid receptor modulators | 科赛普特治疗公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116396303-A | Gimalane-guaiane sesquiterpene dimer and preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-07-07 | — | — | CN | claimed |
| CN-115304516-A | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2022-11-08 | — | — | CN | claimed |
| CN-114727912-A | Cross-linked hyaluronic acid butyrate or butyrate-formate derivative and cross-linking method thereof | 贝曼吉制药公司 | 2022-07-08 | — | — | CN | claimed |
| US-20220025432-A1 | METHOD FOR FLUORESCENCE LABELING OF BIOLOGICAL MATERIALS, THERMALLY REMOVABLE FLUORESCENT LABELS FOR THIS METHOD, AND METHODS OF THEIR PREPARATION AND USE | FUTURESYNTHESIS SPÓLKA Z O.O. (PL) | 2022-01-27 | — | — | US | claimed |
| US-6486321-B2 | EPOXIDATION; QUATERNIZATION | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-11-26 | — | — | US | claimed |
| US-20020133010-A1 | Epoxidation; quaternization | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-09-19 | — | — | US | claimed |
| WO-2002051840-A1 | METHOD FOR PRODUCING THE ANTICHOLINERGIC AGENT TIOTROPIUM BROMIDE | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-07-04 | — | — | WO | claimed |
| US-6403776-B1 | TREATING ANTIBIOTIC COMPOUND WITH NUCLEOPHILE TO CLEAVE PROTECTING GROUP FROM HYDROXYL GROUP | PFIZER INC. | 2002-06-11 | — | — | US | claimed |
| EP-1088828-A2 | Synthesis of carbamate ketolide antibiotics | Pfizer Products Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| EP-0557408-A4 | IMIDAZOLIDINONE COMPOUNDS | — | 1993-10-27 | — | — | EP | claimed |
| EP-0557408-A1 | IMIDAZOLIDINONE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-09-01 | — | — | EP | claimed |
| WO-1992007567-A1 | IMIDAZOLIDINONE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1992-05-14 | — | — | WO | claimed |
| EP-0024538-B1 | 1,2,4-TRIAZOLYL-ENOL ETHERS, PROCESS FOR PREPARING THEM AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1983-01-26 | — | — | EP | claimed |
| EP-0024538-A1 | 1,2,4-Triazolyl-enol ethers, process for preparing them and their use as fungicides | BAYER AG (DE) | 1981-03-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020133010-A1 | Epoxidation; quaternization | TET3, HAO2, PPOX | P2RX7 2362/4885 |
| US-20220025432-A1 | METHOD FOR FLUORESCENCE LABELING OF BIOLOGICAL MATERIALS, THERMALLY REMOVABLE FLUORESCENT LABELS FOR THIS METHOD, AND METHODS OF THEIR PREPARATION AND USE | DUT, NOP2, NUDT1 | P2RX7 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.